Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer. - Paschold L; Schultheiss C; Schmidt-Barbo P; Klinghammer K; Hahn D; Tometten M; Schafhausen P; Blaurock M; Brandt A; Westgaard I; Kowoll S; Stein A; et al. (NPJ precision oncology, 2025)